Achieve the look you envision by speaking to
a healthcare practitioner today.
THE REGENERATIVE BIOSTIMULATOR THAT RENEWS SKIN FROM WITHIN1-6
Image
Aesthetic goals are evolving, 7-10 with people moving beyond facial rejuvenation and age-related concerns toward solutions that elevate body confidence at every stage of life. 11-14 Sculptra® goes beyond simply addressing wrinkles — it strengthens the skin’s foundation for a healthier looking appearance. 15-21
Treatment can be tailored to your goals, whether you wish to improve skin quality, firmness, volume, contour, or a subtle lifting effect. 15,22-31 As the first proven regenerative biostimulator, Sculptra® re-engages your skin’s natural renewal process, stimulating collagen and elastin to progressively enhance firmness, shape, and contour for a naturally sculpted look. 1,6,15-16,19,24-31,33-34,36,38-41
Image
What are regenerative
biostimulator treatments?
biostimulator treatments?
Sculptra® is a unique regenerative biostimulator that is made with the plant-based PLLA-SCA™ formulation.1,38-39,41-42 which works across all 3 skin layers of the skin to renew healthy tissue.36,43-45
Sculptra® targets key components of the skin required to combat signs of aging, including stimulating your own collagen and elastin, with a positive impact on healthy fat.36,40,43-44,46-48
Discover what Sculptra® can do for you
From face to body, Sculptra® helps improve skin firmness, smoothness and radiance — enhancing natural-looking shape and supporting long-lasting confidence. 1,15-16,21,34-35,49-53
Main Image
Explore Sculptra® for your face
Restore natural-looking firmness, smoothness and volume while improving radiance and skin quality — for results that last for more than 2 years. 1,6, 15,19,33-34,54
Secondary Image
Main Image
Explore Sculptra® for your body
Firm, smooth and contour areas such as the arms, posterior thighs, buttocks and décolletage. Patients reported seeing improvements as early as one month after treatment, with continued improvement observed at 2 months and 1 year.*
*Cellulite in the posterior thighs 1,27,30-31, 55-62
Secondary Image
How long do Sculptra treatments last?
Look and feel better with skin that feels like you again—for a long time. People are still satisfied with their facial results more than 2 years after treatment.15, 33-34
For the body, improvements in firmness, smoothness and cellulite appearance are still visible one year after treatment.30
Increase in type I collagen at 3 months - the most important collagen in relation to skin aging40
0
%
Patients who were still satisfied 2 years after treatment15
0
%
Patients who saw firmer skin on the body one year after treatment30
0
%
Image
Image
Image
We are all Sculptra®
Discover real stories from real patients who embarked on a personal journey with Sculptra® over one year.
Image
My Sculptra® Story
Follow patients' Sculptra® Stories and hear what they and their healthcare practitioners have to say about Sculptra®.
Image
1. Sculptra MDR EU IFU 2. Galderma Receives FDA Approval for New SCULPTRA® Label. Galderma 2021. 3. Asius J et al. US patent US 7,731,758 B22(010):2010. 4.Sanofi S.r.l. DEKRA EN ISO 13485:2016 Certificate. Effective Feb 2023. 5.Zhang Y et al. Regen Biomater. 2021;8(5):rbab042. 6.Widgerow A et al. Comparative gene-signature study of PLLA-SCA vs CaHA. Poster, IMCAS 2024 7.Cohen JL, et al. J Cosmet Dermatol. 2023;22(11):2889-2901. 8. Facial Plastic Surgery (2023) As Americans return to the office, AAFPRS unveils aesthetics trends from annual facial plastic surgery survey [Online]. Available at: https://www.aafprs.org/Media/Press_Releases/New-Trends-in-Facial-Plastic-Sur- gery.aspx [Accessed: October 2025]. WGSN (2019) Gen Z: Building New Beauty [Online]. Available at: https://www.wgsn.com/assets/marketing/emails/2019/beauty/ launch/Beauty_Whitepaper_Digital.pdf [Accessed: October 2025]. 10.Liew S, et al. Aesth Plast Surg 2016;40(2):193–201. 1.Triana L, et al. Aesthetic Plast Surg. 2024;48(20):4217-4227. 12. El Hawa M, et al. J Cosmet Dermatol. 2025;24(1):e16624. 13.Fares C, et al. J Cosmet Dermatol. 2025;24(2):e16671. 14.Fabi S. Fillers for the Décolletage Area. https://assets.bmctoday.net/practicaldermatology/pdfs/PD0915_CF_Fillers.pdf [Accessed: October 2025] 15.Fabi S, et al. Poster presented at IMCAS World Congress. 26 -28 January 2023. Paris, France. 16.Bohnert K, et al. Plast Reconstr Surg. 2019;45(5):718–24. 17.Vleggaar D, et al. J Drugs Dermatol. 2008;7(3):209 -20. 18. Li Y, et al. Front Physiol. 2024;15:1346612. 19.Mest DR, Humble G. Dermatol. Surg. 2006;32(11):1336–45.20. Galderma. Data on file (MA-48830). 21. Hexsel D, et al. Dermatol Surg. 2020;46(8):1122–4. 22. Haddad, A et al. Poster presented at IMCAS World Congress. 01-03 February 2024. Paris, France. 23. Bohnert K, et al. Plast Reconstr Surg. 2019;127(4):1684–1692. 24. Fabi S, et al. Dermatol Surg. 2024;50(12):1137-1142. 25. Valantin MA, et al. AIDS. 2003;17(17):2471–7. 26. Sarubi J,et al. J Clin Aesthet Dermatol. 2023;16(6):30-36. 27. Mazzuco R, Sadick NS. Dermatol Surg. 2016;42(3):441-443.28.Munia C, et al. J Clin Aesthet Dermatol. 2022;15(7):38-42. 29. Nikolis A, et al. Dermatol Surg. 2025;51(7):702-709. 30. Beleznay K, et al. Poster presented at IMCAS World Congress. 01-03 February 2024. Paris, France. 31. Haddad A, et al. Aesthetic Plast Surg. 2025;49(5):1507-1517. 32.Nikolis A, et al. J Drugs Dermatol. 2022;21(3):295-304. 33.Brandt FS, et al. Aesthet Surg J. 2011;31(5):521–528. 34. Narins RS, et al. J Am Acad Dermatol. 2010;62(3):448–462. 35. Widgerow A, et al. A randomized, comparative study describing the gene signatures of PLLA-SCA™ and CaHA in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; 01–03 Feb 2024; Paris, France.36. Huth S, et al. J Drugs Dermatol. 2024;23(4):285–288.37. FDA. Summary of safety and effectiveness data. Available at: https://www.fda.gov/medicaldevices/recently-approved-devices/sculptra-p030050s039 [Accessed: August 2025]. 38. Data on file (MA-54151).39. Data on file (MA-46589).40. Goldberg D, et al. Dermatol Surg. 2013;39(6):915–922. 41. FDA. Summary of safety and effectiveness data. Available https://www.accessdata.fda.gov/cdrh_docs/pdf3/p030050s002b.pdf 42.Morgan P, et al. Poster presented at IMCAS World Congress, 26–28 January 2023, Paris, France.43. Waibel J, et al. Poster presented at IMCAS World Congress. 01-03 February 2024. Paris, France. 44. Zubair R, et al. Dermatol Surg. 2024;50(12):1155-1162. 45.Oh S, et al. Antioxidants (Basel). 2023;12(6):1204. 46. Pfisterer K, et al. Front Cell Dev Biol. 2021;9:682414. 47.Kim HW, et al. Ann Dermatol. 2023;35(6):424–31. 48. Trevor LV, et al. J Clin Med. 2020;9(7):2161. 49.Aziz J et al. Skin Pharmacol Physiol. 2016;29(4):190–203. 50. Swift A et al. Aesthet Surg J. 2021;41(10):1107–19. 51.Vierkötter A, Krutmann J. Dermatoendocrinol. 2012;4(3):227–31.52. Zhang S, Duan E. Cell Transplant. 2018;27(5):729–38.53. Filho C DSM et al. Surg Cosmet Dermatol. 2013;5(4):345–50.54.Data on file (MA-48331). 55. Data on file (MA-54104) 56. Joseph J, et al. Poster presented at AMWC. 27-29 March 2024. Monte Carlo, Monaco. 57. Galderma. Data on file (MA-57540). 58.Vanaman M, Fabi S. Plast Reconstr Surg. 2015;136(5 Suppl):276S-281S. 59. Wilkerson E, Goldberg D. J Cosmet Dermatol. 2017;17(4):606-610.60. Coimbra D, et al. Surg Cosmet Dermatol 2012;4(2):182-5. 61. Mazzuco R, et al. J Cosmet Dermatol. 2022;21(12):6727-6733. 62. Lin M, et al. Dermatol Surg. 2020;46(3):386-394. Document ID GL-SCU-2400130
This material refers to the product certified under Regulation (EU) 2017/745 (MDR). Legacy versions of the product remain available. For full product information and the Instructions for Use (IFU), visit: www.galderma.com/library
Always consult a healthcare professional for individualized treatment recommendations and to discuss important
safety information and risks associated with the use of the products.